Cleared Special

K202522 - Synchro SELECT Guidewire (FDA 510(k) Clearance)

Sep 2020
Decision
24d
Days
Class 2
Risk

K202522 is an FDA 510(k) clearance for the Synchro SELECT Guidewire. This device is classified as a Guide, Wire, Catheter, Neurovasculature (Class II - Special Controls, product code MOF).

Submitted by Stryker Neurovascular (Fremont, US). The FDA issued a Cleared decision on September 25, 2020, 24 days after receiving the submission on September 1, 2020.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K202522 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 01, 2020
Decision Date September 25, 2020
Days to Decision 24 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code MOF — Guide, Wire, Catheter, Neurovasculature
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330